Brief: Clover Biopharmaceuticals Posts FY Loss RMB138.5 Mln
27/03/2024 24:50
March 27 (Reuters) - Clover Biopharmaceuticals Ltd
2197.HK :
* LOSS FOR YEAR RMB138.5 MILLION VERSUS LOSS RMB2.45 BILLION
* FY REVENUE RMB39.3 MILLION
Further company coverage: 2197.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clover Biopharmaceuticals
See all newsChina's Clover Biopharma H1 revenue drops sharply, flags going-concern doubt
Brief: Clover Biopharmaceuticals Posts FY Loss Of RMB205.1 MLN
Brief: Clover Announces Positive Phase I Clinical Data For Rsv-Hmpv-Piv3 Combination Vaccines And For Rsv Re-Vaccination In Older Adults
Brief: Clover Biopharmaceuticals Posts H1 Revenue Of RMB3.3 Million
Brief: Clover Biopharmaceuticals Says It Terminates Cooperation With Adimmune